Dato DXd (ADC) Approved by U.S. FDA for Lung Cancer
Dato DXd (datopotamab deruxtecan) has received U.S. FDA approval – a breakthrough milestone announced jointly…
News
Bio-Thera’s Anti VEGF Therapy for w-AMD Meets Phase III Endpoint, Prepares for Market Filing
— Reported by DengYueMed On June 24, 2024, Bio-Thera Solutions, Ltd. announced that its anti…
Molecular Glues: The Next Golden Track in Drug Discovery
Molecular Glues: Unique Mechanism Of Action Wide Market Prospects Earlier this year, AbbVie announced a…
Krazati (Adagrasib): A Comprehensive Guide for Lung Cancer Patients
Krazati (adagrasib) is a promising targeted therapy developed to treat certain cancers with a specific…
Amvuttra (Vutrisiran) Injection: A Comprehensive Patient Guide
Introduction Amvuttra dosing (vutrisiran) is a new-generation RNA interference (RNAi) therapy used for the treatment…
Can You Recover From Breast Cancer? Breast Cancer Symptoms & Treatments
Introduction Diagnosed with breast cancer? You’re not alone. Explore this blog to understand what breast…
Why Does ES-SCLC Remain So Deadly?
Extensive-stage small-cell lung cancer (ES-SCLC) is an aggressive form of lung cancer, accounting for ~70% of…
How to Manage Anaplastic Lymphoma Kinase (ALK) Cancer: Targeted Therapies and Strategies for Better Outcomes
Introduction Anaplastic Lymphoma Kinase (ALK) is a genetic mutation that can drive the development of…
Is Diffuse Large B-cell Lymphoma Still an Unsolved Puzzle in Precision Oncology?
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL), accounting…
Is Colorectal Cancer Curable? From Symptoms to Survival
Introduction “It was just some blood in my stool. I thought it was hemorrhoids. But…